| Value | ₹40.28 Cr |
|---|
BSE filing, NSE: CYBERTECH. Summary written from the filing by ALFA Finder's alert engine.
Cybertech Systems & Software Ltd: key numbers
- Share price
- ₹122.47
- Market cap
- ₹370.9 Cr
- Revenue (annual)
- ₹237.2 Cr
- Net profit (annual)
- ₹30.43 Cr
- P/E (TTM)
- 11.7×Sector 23.5×
- Promoter holding
- 37.95%-0.09% QoQ
- FII holding
- 0.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cybertech Systems & Software Ltd
All →Cybertech Systems & Software Investor Presentation: Key Takeaways
Q2FY27 operating revenue ₹733.0 Mn (+24.7% YoY), total revenue ₹780.3 Mn (+16.9%), PAT ₹86.8 Mn (flat YoY). EBITDA margin 16.4% vs 18.8%. Strategy centres on AI-assisted delivery, specialised engineering and cloud.
Cybertech Systems & Software Q2 FY27 Results: Net Profit ₹8.7 Cr, Up 0.0% YoY
Cybertech Systems & Software Ltd reported revenue from operations of ₹73.3 Cr (+24.7% YoY) and net profit of ₹8.7 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.7 Cr · +0.0% YoY
Cybertech Systems & Software Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI (LODR) regulations.
Cybertech Systems & Software Board Meeting Date
CyberTech Systems and Software Limited scheduled a Board Meeting on October 22, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Cybertech Systems & Software Annual General Meeting
CyberTech Systems and Software Limited conducted its 31st Annual General Meeting on September 28, 2026, to adopt financial statements and declare dividends.
Cybertech Systems & Software Other Announcement
CyberTech informs shareholders with unregistered email IDs about the upcoming AGM and provides the annual report link, while also reminding about KYC update requirements.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.